Avalyn Pharma (NASDAQ:AVLN) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Avalyn Pharma (NASDAQ:AVLN) to a hold rating in a research report released on Saturday.

Avalyn Pharma Stock Performance

Shares of AVLN opened at $27.33 on Friday. Avalyn Pharma has a 12-month low of $25.05 and a 12-month high of $30.67.

Insider Activity

In related news, Director Jill Carroll acquired 277,778 shares of Avalyn Pharma stock in a transaction that occurred on Friday, May 1st. The shares were purchased at an average cost of $18.00 per share, for a total transaction of $5,000,004.00. Following the acquisition, the director owned 2,186,562 shares in the company, valued at approximately $39,358,116. This represents a 14.55% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, major shareholder Sr One Capital Management, Llc purchased 555,555 shares of the business’s stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $18.00 per share, for a total transaction of $9,999,990.00. Following the completion of the purchase, the insider directly owned 2,186,562 shares of the company’s stock, valued at approximately $39,358,116. This trade represents a 34.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure.